CMS Issued Coverage Guidance on GLP-1 Anti-Obesity Drugs Requiring Considerations for Health Plans GLP-1s (glucagon-like peptide 1 agonist) came up in the news again after…
PBM Alternative Pricing Models Require Thoughtful Consideration For Plan Sponsors PBM alternative pricing models are being rolled out by some of the biggest organizations in…
In the complex landscape of healthcare, the escalating costs of drugs have become a pressing concern. To learn more about how pharmacy managed care is…
Sickle Cell Disease Sickle cell disease is an inherited blood disorder that impacts over 100,000 people in the United States and is most common within…